Drugs / Grifola Frondosa
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01200004 | Apr 2012 → Jul 2013 | — | M.D. Anderson Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
| Phase 21 trial | ||||||
| Phase 2 | NCT01099917 | Apr 2010 → Sep 2014 | myelodysplastic syndrome | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Grifola Frondosa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01200004 ↗ |
| Known as | Maitake | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01099917 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a medicinal mushroom extract called Maitake” NCT01099917 ↗ |
| Route | Oral | “by mouth” NCT01099917 ↗ |